BETA - Beta Drugs | Wealthrox

← Go Back

Beta Drugs

BETA · Pharma > Pharmaceuticals & Drugs · Chairman: Rahul Batra · MD: Rahul Batra · Listing date: Oct. 13, 2017

Stock Price vs Company Growth

0.0%

26.8%

57.0%

69.2%

20.8%

190.1%

44.1%

all

40.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,872 0%

1,050

1,966

Company Overview

Sales

363 Cr

Growth: 1.8%

Profit after Tax

35.5 Cr

Growth: 0.3%

Small Cap

2,075 Cr

P/E: 51.9x

Industry P/E: 31.1x

Fundamentals

Sales (Cr)	₹ 363
Growth	1.8%
EBITDA	19.4%
P/S	5.7x
Dividend	0.0%
P/E	51.9x
Book Value	₹ 194
PEG Ratio	29.6x
ROE	18.1%
P/B	9.8x

Shareholding Pattern

Institutions

Suryavanshi Commotrade Private Limited

6.71 %

Ashish Kacholia

4.93 %

Bsas Infotech Ltd

1.27 %

Ankush Kedia

1.12 %

Onkar Singh

1.05 %

Promoters

Vijay Kumar Batra

65.69 %

Rahul Batra

0.36 %

Varun Batra

0.35 %

Neeraj Batra

0.28 %

Heena Batra

0.01 %

Others

Increase Decrease No change

Company Profile Detailed

Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.

Investors (7)

onkar.si...

airavat....

bsas.inf...

Followers (1)

random